Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.11 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.11 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.11 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.11 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.11 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.11 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.11 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.11 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.428EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.428ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.428EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.428EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.428ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.428ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.355EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.355ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.355ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.355EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.355EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.355ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.355ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AH.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AH.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AH.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AH.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.289EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.289ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.289ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.289EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.289EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.289ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.289ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.365EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.365EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.365ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.365ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used